{"title": "Pfizer's Massive Upside Potential", "selftext": "Pfizer has a TON of upside potential. Here are a few different reasons why it could go to the moon.\n\n1. As of time of posting, only 50% of the US population is fully vaccinated (2 shots) against COVID and only 36.1% of the world population is fully vaccinated. (Source: [https://ourworldindata.org/covid-vaccinations](https://ourworldindata.org/covid-vaccinations)). Once Pfizer stops selling vaccine to the US, is it going to stop production? No, it will start selling to the rest of the world. Moderna just jumped 17% earlier this week when it was announced that they will start selling to Australia. We could see a 10-20% pop each times the news announce that Pfizer is selling to another country!\n2. There are still debaters out there so I'm not going to argue whether the vaccine works. The bigger point is that the government is paying for the vaccines and they believe the vaccine works. Therefore, US demand will literally be capped tits high until more of the US population is fully vaccination. Even once US demand dries up, the rest of the world will still be waiting for our extra supply for a long time.\n3. There are new variants. With the delta variant, Pfizer has already publicly said that a third booster will help. Imagine if the US gov announces they will start paying for 3rd vaccinations? What if an Epsilon or Zeta variant starts blowing up? Would they pay for a 4th or 5th vaccination?\n4. Gain comparison. Moderna has gained 253% since January 1st, 2021, even after the latest price correction. By contrast, Pfizer has only gained 31%.\n5. Solid Financials. During the last 2 earnings releases (where the effects of COVID vaccines have shown an impact), Pfizer outperformed EPS by \\~+20% and +10%. Due to the current trend with COVID, I expect this to go on at least for another year.\n6. This can be used as a hedge. If a new variant comes out and the S&P reacts adversely to it, at least Pfizer should be able to maintain value/go up because Pfizer/moderna/biontech would be most situated to come up with a response. \n\nEdit: The main concern seems to be that Pfizer is too big a company for COVID vaccination revenue to move the stock price. In Q2'21, Pfizer reported $19B of revenue, of which $7.8B came from COVID shots. By contrast, Moderna reported $4.4B of revenue. I would agree if COVID shots were only <10% of total revenue, but at \\~40% it's a different story. (source: [https://www.cnbc.com/2021/07/28/covid-pfizer-pfe-earnings-q2-2021.html](https://www.cnbc.com/2021/07/28/covid-pfizer-pfe-earnings-q2-2021.html) and [https://www.pmlive.com/pharma\\_news/modernas\\_stellar\\_rise\\_continues\\_with\\_revenues\\_of\\_$4.4bn\\_in\\_q2\\_1374425](https://www.pmlive.com/pharma_news/modernas_stellar_rise_continues_with_revenues_of_$4.4bn_in_q2_1374425))\n\nEdit 2: I've recently seen some concerning data that some of the comments brought up about the Pfizer vaccine having 40% efficacy vs the delta variant. This is based off a Mayo clinic study. There is also a separate New England Journal of Medicine study that showed Pfizer was 88% effective vs the delta variant. Both sources linked below.\n\nThe Mayo clinic study itself is pretty technical and hard to read, but I think the tables in the back are easier to understand for laymen like myself. In page 20, there is a table that shows the overall efficacy rates. On or after 14 days following the second dose, 7 out of 4,198,947 had COVID-19 associated ICU admissions. 0 out of 4,199,985 had COVID-19 associated deaths.\n\nTo me, this shows that the Pfizer vaccine indeed does do a ton to prevent serious illness and death. It may not be as effective at preventing someone from actually getting delta variant, but it would sure increase your chances of survival drastically if you did get it. A 4 million people sample size is definitely large enough to be statistically significant. I hate that a lot of times, news channels pick and choose statistics without showing the whole story in order to sell views. Mayo Clinic itself even states ‚ÄúMayo Clinic is aware of media reports on the scientific preprint paper comparing vaccines‚Äô clinical effectiveness against the delta variant and breakthrough infections,\" a statement from Mayo Clinic says. \"We caution against drawing conclusions about vaccine effectiveness from a preprint study, which is intended only to be helpful to the scientific community and has not yet undergone the rigor of peer review.‚Äù\n\nTo me, the jury is still out on the efficacy of Pfizer vs the delta variant, but it sure as hell seems to prevent death and/or serious illness.\n\nSources:\nMayo clinic: https://www.medrxiv.org/content/10.1101/2021.08.06.21261707v1.full.pdf\nNew England Journal of Medicine: https://www.contagionlive.com/view/two-dose-covid-19-vaccines-remain-effective-versus-delta-variant", "id": "p3otnm", "created_utc": 1628872732.0, "score": 41, "upvote_ratio": 0.68, "num_comments": 95, "comments": [{"body": "\n**User Report**| | | |\n:--|:--|:--|:--\n**Total Submissions**|1|**First Seen In WSB**|1 month ago\n**Total Comments**|4|**Previous DD**|\n**Account Age**|3 years|[^scan ^comment ](https://www.reddit.com/message/compose/?to=VisualMod&subject=scan_comment&message=Replace%20this%20text%20with%20a%20comment%20ID%20(which%20looks%20like%20*h26cq3k*)%20to%20have%20the%20bot%20scan%20your%20comment%20and%20correct%20your%20first%20seen%20date.)|[^scan ^submission ](https://www.reddit.com/message/compose/?to=VisualMod&subject=scan_submission&message=Replace%20this%20text%20with%20a%20submission%20ID%20(which%20looks%20like%20*h26cq3k*)%20to%20have%20the%20bot%20scan%20your%20submission%20and%20correct%20your%20first%20seen%20date.)\n    \nHey /u/JASONLIU07, **positions or ban.** Reply to this with a screenshot of your entry/exit.", "score": 1, "replies": [{"body": "https://imgur.com/dn7Sbh5", "score": 1, "replies": []}, {"body": "This guy looks like a shill. Positions or ban", "score": 1, "replies": [{"body": "Did not realize my positions did not post because I did not have 100 karma when I initially made this post. I normally just lurk rather than post. If you don't like the stock, just don't buy it, why bash me?", "score": 1, "replies": []}]}]}, {"body": "January 2022 calls $60 strike holding at 600% gains thus far. Watching the short exp date call folks squirm is fun.", "score": 12, "replies": [{"body": "Up 600% on leaps in a stock that has barely made any gains in 20+ years, and still holding?\n\nBold strategy, Cotton.", "score": 26, "replies": [{"body": "I know. Part of me says sell asap. Part says hold into September.", "score": 4, "replies": [{"body": "These will go in the money, maybe my 2023, but the break of that ATH is more significant than most understand.", "score": 2, "replies": [{"body": "They've been ITM since last week.", "score": 1, "replies": []}]}, {"body": "I'm considering selling my options and just holding stock, maybe buy back in on a drop. It's seen a massive run. You?", "score": 1, "replies": [{"body": "I sold at 1120% gain this morning. Seemed wise. Maybe I'm a wussy for doing it but 1120% gains in a week and a half seemed reasonable.", "score": 1, "replies": [{"body": "Nah no shame in locking in gains. I think I'm doing the same. I still believe in the thesis though hence still holding shares but I'm going to lock in gains on the options.", "score": 1, "replies": []}]}]}, {"body": "How big a position? Cause Tbh...if it was me, I‚Äôd take the 6 bagger. Not very often people 6x...especially on a stock that historically doesn‚Äôt move very much.", "score": 1, "replies": [{"body": "Holding ten contracts. Nothing huge. Paid next to nothing for them, so I sort of feel like just riding it out into september. Expiration is January", "score": 2, "replies": [{"body": "Ah. Well if it‚Äôs a small amount let it ride then, might as well. Since this is WSB I thought it was a true yolo of half your account or more lol.", "score": 0, "replies": [{"body": "Full disclosure, my position is also tiny because I'm very risk adverse.", "score": 1, "replies": []}, {"body": "No that was my old handle, u/derpderp2020 and the one week 23k spy put loss.", "score": 0, "replies": [{"body": "I also have a very small position, but I believe there are a lot of small things that could happen to make the stock shoot up, namely any governmental announcements of additional vaccine mandates, any international countries announcing adoption of Pfizer vaccine, any new variant spread, etc...", "score": 0, "replies": [{"body": "COVID vaccines are priced in at this point. They had a new encephalitis drug approved by the FDA last week, and those are the type of things than can push future potential sentiment and drive price up. I'm only in it for the short term gains though this time.", "score": 3, "replies": [{"body": "I agree that in a perfect environment, everything is priced in. I think that's one of the core concepts we learn in MBA. But what I've seen is that in actuality, there are SO MANY gaps. That's why stocks can keep going up or down on days when there are no significant news. If everything was fully priced in, stocks should only move on significant new information. In general though, I hold the same approach you do and most of my portfolio is in VOO and I just buy/hold. I only stick my limb out for exceptions, and I feel this could be one.  \n\n\nOne more thing is that when US becomes closer to full vacination and these vaccines start going out more widespread to other countries, the Pfizer name will count. If you were buying a vaccine from another country, I'd imagine governments to go with the name brand if the costs were comparable.", "score": 1, "replies": []}]}]}]}]}]}]}]}]}, {"body": "You think it‚Äôs gonna reach $60 by Jan?", "score": 5, "replies": [{"body": "I don't think it will be at $60 by January. Do I think it may touch $60 or get closer than it is now - yes. If it did, I don't think it could be sustained.", "score": 2, "replies": [{"body": "Wym by Jan strike calls 600%?", "score": 1, "replies": [{"body": "Down to 516% today but yes. Contract price is .72 now.", "score": 1, "replies": []}]}]}, {"body": "For these kinds of these, I don't see why not. There are any number of catalysts. Both Moderna and BioNTech have nearly 4x'd. Given this is half of Pfizers revenue, I don't see why Pfizer couldn't 2x. January is a very tight timeline though... so... really no idea. I always been burned by trying to time the market but have generally have much more success finding good strategies for longer term holding.", "score": 2, "replies": []}]}]}, {"body": "Pfizer is the HSBC of the pharmaceutical industry.", "score": 8, "replies": [{"body": "I assume this is a - the share price won't do shit no matter what - statement", "score": 4, "replies": [{"body": "RICO", "score": 6, "replies": []}]}, {"body": "From Hong Kong?", "score": 2, "replies": []}, {"body": "So. . . As in they have exclusive rights dealing with cartels?", "score": 2, "replies": []}, {"body": "That's an interesting perspective, looked up Pfizer total Q2 revenue at $19B vs Moderna at $4.35B, so Pfizer is definitely much bigger. However, it doesn't seem so much bigger that the COVID vaccine wouldn't move the stock price (Moderna moved +253%, even a fourth of that should still be +\\~63%)", "score": 1, "replies": []}]}, {"body": "I‚Äôm heavy in calls, see u $50+ Monday", "score": 6, "replies": [{"body": "Let's goooo", "score": 2, "replies": [{"body": "It was obvious they were loading in, you see that new FDA approval news? EZ MONEY baby. Im planning on holding", "score": 2, "replies": []}]}]}, {"body": "I bought one contract set to expire in 10 months. It would be hilarious if it boomed like moderna. Best 69 dollars I ever spent", "score": 7, "replies": []}, {"body": "Any pharm company using MRNA technology is going to flourish, this is a new level breakthrough for our technology.. I'll buy a share of something", "score": 6, "replies": []}, {"body": "People are gonna start listing their vaccinations like frats....Yeah Bro, I got the Delta Sigma Pi shots, pass me the beerbong", "score": 8, "replies": []}, {"body": "And it has a smaller P/E ratio than its peers", "score": 4, "replies": [{"body": "Current P/E is \\~14, historically an ok value and priced right, but in this day and age that could leave a lot of room to run. Their earnings have been dampened because they've been selling the vaccine for so cheap, but I bet the price will come up on the booster shots, no reason they should be letting those go for $22 each.", "score": 3, "replies": []}]}, {"body": "Lol you still don‚Äôt get that Pfizer is not getting much from this vaccine business most of the money is going to BioNtech hence why it‚Äôs up 376% YTD vs only 31% rise for Pfizer. Pfizer is the distributor and it‚Äôs a big company already and we‚Äôll established with big portfolio of products unlike bioNtech which is still experimenting with Mrna to develop new products for complicated or lethal diseases", "score": 8, "replies": [{"body": "I might be missing something and would gladly welcome the clarification. In their Q2'21 earnings, Pfizer reported $7.8B of COVID revenue. BioNTech reported Q2 revenue of approx 5.3B euros. Seems to me that Pfizer is getting as much as BioNTech and Moderna?\r  \n\r  \nhttps://www.cnbc.com/2021/07/28/covid-pfizer-pfe-earnings-q2-2021.html and https://www.fool.com/earnings/call-transcripts/2021/08/09/biontech-se-bntx-q2-2021-earnings-call-transcript/#:\\~:text=We%20recorded%20Q2%20revenues%20of,vaccine%20production%20and%20delivery%20worldwide.", "score": 4, "replies": []}, {"body": "Bntx is 90b market cap\nPfizer is 270b market cap\nBig big difference", "score": 1, "replies": [{"body": "But shouldn't the revenue as a % of market cap factor directly into the growth? Given approx. equiv revenue, shouldn't we expect Pfizer to grow at 1/3 of what Bntx has? As a hypothetical, let's say both Bntx and Pfizer both gain 90b additional market cap as a result of the vaccine. Bntx goes to 180b, which is a 100% increase from 90b. Pfizer goes to 360b, which is a 33% increase from 270b.", "score": 1, "replies": [{"body": "You literally just answered your own question‚Ä¶. Bntx‚Äôs 300% growth is pfizer‚Äôs 30% growth, 90b = 90b", "score": 0, "replies": [{"body": "Based on my math above, a 100% biontech growth = 30% Pfizer growth. Biontech grew 371% so Pfizer should grow 120% right?", "score": 1, "replies": []}]}]}]}]}, {"body": "Can it go ape shit before September 24 bc calls.", "score": 3, "replies": [{"body": "Honestly don't see why not, but the safer play would obv be to buy stocks. That being said, I'm also in calls.", "score": 1, "replies": [{"body": "Bought shares this morning, gods speed", "score": 2, "replies": []}]}]}, {"body": "The best thing about Pfizer is they can manufacture much more efficiently and fill orders. They‚Äôre so diverse in their manufacturing line, they‚Äôve been able to switch production to focus on vaccine as primary. \n\nModerna can‚Äôt even fill orders promised to South Korea in July. 40M shots and they‚Äôve only delivered 2.5M as of yesterday. How are they going to provide to any other county? But today, literally 12 hours ago, SK just ordered 30M shots from Pfizer. \n\nPfizer‚Äôs been around for 174 years. No where to go but UP.", "score": 4, "replies": [{"body": "Yeah but, Unless the vaccine doesn‚Äôt work and the US is the only one‚Äôs buying it. https://fortune.com/2021/08/11/pfizer-covid-vaccine-delta-variant-low-effectiveness-stock-falls/.\n\nOr Maybe the severe drop off in efficacy after 6 months is planned obsolescence, in which case brilliant move by Pfizer. Now if only they can produce a vaccine which will mutate the virus in a way only Pfizer vaccines can inoculate. \n\nThe idea that Pfizer will take the world‚Äôs share of vaccine bc Moderna can‚Äôt produce is a pipe dream. I watched the WHO vaccine meeting this week. There are several other vaccines that will be EUA‚Äôd by WHO I‚Äôm coming months. Many of them cheaper to produce and transport, more effective,  and have had actual clinical trials. Pfizer‚Äôs vaccine is a scam, is beginning to realize it.", "score": 1, "replies": [{"body": "Yep if Pfizer vaccine doesn't work and they can't sell it, then PFE is fked.", "score": 1, "replies": []}]}]}, {"body": "Fucker like OP posts this garbage after the stock has already made a massive run, fuck you.", "score": 3, "replies": [{"body": "If you look at my history, I've been lurking for 3 years without posting. A major reason is that I don't want my ideas to cause people to lose money. However, after thinking about it more, I still believed in this idea and thus wanted to share it. It's not like I gain anything from posting it now as opposed to posting it earlier...", "score": 2, "replies": [{"body": "Also, I was just not very confident in general. However, the past 2 weeks has given me the confidence (misguided though it could be) that pushed me to post the idea.", "score": 3, "replies": []}]}]}, {"body": "[removed]", "score": 3, "replies": [{"body": "I would agree if pfe did not just announce in Q2'21 earnings that they reported $7.8B of COVID revenue this last quarter. In their 10Q, Pfizer unfortunately does not show revenue by product, but they do show it by product segment. \"Vaccines\" grew from $1.2B to $9.2B YoY. This is roughly in-line with having $7.8B of COVID revenue.", "score": 5, "replies": []}, {"body": "Edit:\n\nPfizer is a drug development company and global manufacturer in like 30+ sites around the world. They‚Äôve been in business for 174 years.", "score": 2, "replies": []}]}, {"body": "Pfizer makes like 42 Billion a year. I don't think the once off revenue from the vaccines are gonna make a big difference. The cost of the vaccine is apparently about 20 dollars, with most of it going to BioNtech. Most of this is priced in already I think.", "score": 1, "replies": []}, {"body": "The best case you have presented here is that the US Govt is paying for the vaccines whether they work or not. \n\nHowever, Israel Israel, Canada,Japan, are all signing deals w MRNA because Pfizer far less effective.\n\nhttps://www.axios.com/coronavirus-vaccines-pfizer-moderna-delta-biden-e9be4bb0-3d10-4f56-8054-5410be357070.html\n\n\nFurthermore, PFF has a market cap of 271.B, the 27B deal with US moved the stock ~6% higher than its previous high this year. Just because the CDC, and DC are lip-locked in a 69 with Pfizer, doesn‚Äôt mean it‚Äôs worth anything more than Joe Biden‚Äôs medicated boner.", "score": 1, "replies": [{"body": "Hoping Pfizer senior management/strategy is hard at work on boosters that will increase this efficacy vs Delta. They certainly have the resources to do so and should be their #1 R&D priority. If they come up with anything or even just puts out a paid study, I could see the stock jumping as well. This is good support as to why Pfizer hasn't seen the gains moderna has though.", "score": 1, "replies": [{"body": "What are you talking about? Pfizer hasn‚Äôt seen the gains MRNA because the market cap is 100B less, even after the 2000% gains. \n\nFurthermore Pfizer‚Äôs vaccine doesn‚Äôt work! There are better vaccines already authorized and more coming. \n\nI don‚Äôt think you‚Äôre interested in the stock. \n\nPosistions or ban.", "score": 1, "replies": []}]}]}, {"body": "I will not invest in a company that willingly profits off the misery of human beings. Fuck Pharma.", "score": 0, "replies": [{"body": "Without pharma life would be way worse if even possible...", "score": 5, "replies": []}, {"body": "I can understand the sentiment. However, I think a big distinction is that they are not the ones causing the misery in the first place. They found a way to alleviate the misery and in a capitalist society, is making money off that. I would argue that this is better than not having a cure at all.", "score": 2, "replies": [{"body": "One doesn‚Äôt need a vaccine for a ‚Äòdisease‚Äô that has a natural 99.87% recovery rate. (This statistic is readily available for those bothered to look). \n\nNo offence to anyone who invests in big pharma. There is big money to be made, but my conscience and ethics won‚Äôt let me do it. It goes for other companies like Coca Cola and McDonald‚Äôs etc.", "score": 0, "replies": []}]}]}, {"body": "Nah, finna buy puts.  40% efficacy, so nobody wants that shit.  üòÇ", "score": 0, "replies": [{"body": "Why not buy puts in Moderna or BioNTech? They have experienced far more growth so if the argument is that the vaccine sucks and the government won't buy it anymore, those stocks will tank far more.", "score": 2, "replies": [{"body": "Trust me I‚Äôm holding moderna puts.  They were just too far out of the money to make a real gain on that $80 drop.", "score": 0, "replies": [{"body": "I've recently seen some concerning data that some of the comments has brought up about the Pfizer vaccine having 40% efficacy vs the delta variant. This is based off a Mayo clinic study. There was also a separate New England Journal of Medicine study that showed Pfizer was 88% effective vs the delta variant. Both sources linked below.\n\nThe Mayo clinic study itself is pretty technical and hard to read, but I think the tables in the back are easier to understand for laymen like myself. In page 20, there is a table that shows the overall efficacy rates. On or after 14 days following the second dose, 7 out of 4,198,947 had COVID-19 associated ICU admissions. 0 out of 4,199,985 had COVID-19 associated deaths.\n\nTo me, this shows that the Pfizer vaccine indeed does do a ton to prevent serious illness and death. It may not be as effective at preventing someone from actually getting delta variant, but it would sure increase your chances of survival drastically if you did get it. 4 million people samples size is definitely large enough to be statistically significant. I hate that a lot of times, news channels pick and choose statistics without showing the whole story in order to sell views. Mayo Clinic itself even states ‚ÄúMayo Clinic is aware of media reports on the scientific preprint paper comparing vaccines‚Äô clinical effectiveness against the delta variant and breakthrough infections,\" a statement from Mayo Clinic says. \"We caution against drawing conclusions about vaccine effectiveness from a preprint study, which is intended only to be helpful to the scientific community and has not yet undergone the rigor of peer review.‚Äù\n\nTo me, the jury is still out on the efficacy of Pfizer vs the delta variant, but it sure as hell seems to prevent death and/or serious illness.\n\nSources:Mayo clinic: [https://www.medrxiv.org/content/10.1101/2021.08.06.21261707v1.full.pdf](https://www.medrxiv.org/content/10.1101/2021.08.06.21261707v1.full.pdf)New England Journal of Medicine: [https://www.contagionlive.com/view/two-dose-covid-19-vaccines-remain-effective-versus-delta-variant](https://www.contagionlive.com/view/two-dose-covid-19-vaccines-remain-effective-versus-delta-variant)", "score": 1, "replies": [{"body": "Yeah data is data.  Not finna argue it.  But what the mass population thinks about that is what the market is going to price in.  üòÇ", "score": 2, "replies": []}]}]}]}]}, {"body": "This stock goes nowhere, take profits ASAP", "score": -1, "replies": [{"body": "It‚Äôs been reliably going up all year. Da fuck are you talking about? It‚Äôs as consistent as you can get.", "score": 5, "replies": [{"body": "Pfizer is a bunny hopping up the stairs. Look at the 1-year chart. It‚Äôs incredible.", "score": 2, "replies": []}]}]}, {"body": "Moderna better growth", "score": 1, "replies": [{"body": "I don't really see it as a Pfizer vs Moderna discussion, more so as a play on vaccines. Sure you can get some Pfizer and some Moderna to diversify. The problem I have is that Moderna has already grown so much (from $111 per share on 1/1/21 to $390 per share today). BioNTech has grown even more than that.\r  \n\r  \nPfizer has not yet seen that tremendous growth. Others have argued that this is because the COVID vaccine is only a small percentage of their revenue which I think is the current Wall Street justification, but when I look up their COVID shots revenue as a percentage of total revenue this quarter, it's actually quite high (\\~40%).", "score": 1, "replies": []}]}, {"body": "Or massive downside if it turns out delta is resistant to the vaccine..... or that there are serious side effects discovered over the longer term and they get sued by everyone who got their jab....", "score": 1, "replies": [{"body": "You actually can't sue if there are negative side effects. See source: [https://www.cnbc.com/2020/12/16/covid-vaccine-side-effects-compensation-lawsuit.html#:\\~:text=Health%20and%20Science-,You%20can't%20sue%20Pfizer%20or%20Moderna%20if%20you%20have,compensate%20you%20for%20damages%20either&text=Under%20the%20PREP%20Act%2C%20companies,goes%20wrong%20with%20their%20vaccines](https://www.cnbc.com/2020/12/16/covid-vaccine-side-effects-compensation-lawsuit.html#:~:text=Health%20and%20Science-,You%20can't%20sue%20Pfizer%20or%20Moderna%20if%20you%20have,compensate%20you%20for%20damages%20either&text=Under%20the%20PREP%20Act%2C%20companies,goes%20wrong%20with%20their%20vaccines).  \n\n\nApparently FDA has also started authorizing third shots. [https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-vaccine-dose-certain-immunocompromised](https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-vaccine-dose-certain-immunocompromised). The question really isn't how strong the vaccine is against the delta variant, but whether the government/governments are willing to pay for a third shot, and the current trend is that they are. Most governments' priority right now is to curb COVID 19.", "score": 2, "replies": []}]}, {"body": "What is your PT in, say, 3 months?", "score": 1, "replies": [{"body": "Honestly, really hard to say since this isn't a play on fundamentals and I don't have a strong background in technical analysis. Just based on math though, Moderna and BioNTech has seen roughly 100% gains in the past 3 months. They've all roughly reported the same revenue from the vaccine. However, COVID shots only make up roughly 40% of Pfizers Q2 revenue. If they made up 100% of revenue and gained 100%, I'd hope for them to gain 40% if they made up of 40% of revenue. So 1.4\\*$48= $67. Pretty ambitious, I know. Major assumption here is that the past 3 months repeat, which it likely **will not**.", "score": 2, "replies": [{"body": "I have similar convictions for pfe though", "score": 1, "replies": []}]}]}, {"body": "You‚Äôre forgetting they share float comparable to Moderna.. how tf could a company with 5.6B shares moon?", "score": 1, "replies": []}]}
{"title": "Due Diligence Nokia (NOK)", "selftext": "\nI originally had a lot of links in this, but it led to the post getting auto-removed. Let me know if you would like any sources.\n\n# History of Nokia\n\nIf you've seen any of the recent Nokia posts over the last few months, a common comment you will see is: \"Nokia?!? That stock has been trading sideways for years!\"\n\nWhile yes that is true, it is important to understand why. Let's take a look.\n\n**2000-2013**\n\nNokia dominated the mobile phone market during this time due to a quality handset. NOK traded in the $50s during the Dotcom bubble and in $30s before the housing crash. However, they never recovered after 2008 due to struggling to keep up in software as the mobile phone market started to shift to smart phones.\n\n**2013-2019**\n\nWhen Nokia realized that trying to stay in the phone space was a losing battle they sold their phone division to Microsoft in 2013. For the next 3 years, Nokia was a large company in disarray.\n\nThis did not get much better in 2016 when they acquired Alcatel-Lucent and decided to focus on networks. The merger did not go as smoothly as planned and over the next 5 years Nokia started \"trading sideways\" due to a bearish sentiment.\n\nSome investors stuck around through all of this due to a dividend being paid out, but that was suspended in 2019 so Nokia could focus on developing its 5G mobile networks. This dropped the share price down to $3.50.\n\n**2020-Present**\n\nIn March 2020, sentiment started to change somewhat bullish as they announced Pekka Lundmark would be taking over as CEO. Pekka worked for Nokia for a decade in the 90s and most notably served as Fortum's, a Finnish state-owned energy company, CEO from 2015 to 2020.\n\nThe bullish sentiment was shorted lived due to the pandemic crash dropping the share price to $2.42. It started to pick back up over the summer when it was announced that Pekka would take over a month earlier than planned.\n\nThis was followed by rumors that there was a chance Nokia could win Verizon's $6 billion 5G deal. Hype around this brought Nokia's price above $5 for the first time since they suspended their dividend in October 2019. But in September, it was announced that Samsung won the Verizon deal and NOK fell down to $3.78. It fell even further to $3.37 in October when the rest of the market saw a down swing.\n\nThen it climbed back up to the low $4s, had a crazy January hitting $9.79 for about 10 seconds during to the meme stock frenzy, and has since returned to the high $3s low $4s after the Q4 earnings call.\n\n**Pekka's Tenure**\n\nPekka has been in charge for 11 months during a global pandemic, but he has been able to make some progress it appears. Much of this information can be found in the Nokia 2020 Annual Report.\n\n* He trimmed their employee size by 11,000.\n* He improved their free cash flow to $2.6 billion.\n* Even with the decrease in revenue he nearly doubled their operating profit (page 82).\n* He drastically reduced their net deferred tax balance (page 175).\n* He created four distinct business groups with plans for these groups to be shared in more detail during during Capital Markets Day on 3/18.\n* He replaced Nokia's CFO, CTO, and CMO (CFO happened before he took over)\n* It appears he issued new shares to leadership.\n* Pekka has a stake in the company (page 67 of annual report) with a long term goal to \"Focus on increase in share price and restoration of the dividend\".\n   * \" In addition, Mr. Lundmark received an award of EUR 1.3 million of restricted shares on joining to buy out the awards he forfeited on leaving his previous employer. Mr. Lundmark was invited to join the co-investment based long-term incentive arrangement (eLTI) targeted to engage senior leaders with the long-term nature of our business and share price, and purchased EUR 2.6 million of Nokia shares against which he was given a matching award of EUR 5.2 million of Nokia 2020 performance shares. This investment by Mr. Lundmark aligns him with¬†shareholders from the start and is a sign of his commitment and¬†engagement with the company. Delivery of actual Nokia shares would take place in 2023 subject to performance conditions\"\n\n# Bullish\n\nHere is a list of 28 deals and partnerships Nokia has established since December 2020. Some of these deals are not massive, but they span across 6 continents.\n\n**Largescale Network**\n\n* 5 year Multi Billion Dollar T Mobile Deal\n* 7 year Belgium deal\n* Deutsche Telekom in Germany\n* France's Mainland 5G Network\n* 5G Network in Austria\n* Telecom Italia\n* Cibicom ISP in Denmark\n* Polkomtel Phone Provider in Poland\n* Telenor Group in Thailand\n* Ooredoo in Algeria\n* 5G Network in Philippines\n* Tele2 in Sweden, Latvia, Lithuania, and Estonia\n* Ecuador\n* Vodafone in Australia\n* Saudi Arabia\n* Singapore\n\n**Private 5G Deals**\n\n* San Diego Gas &amp;amp; Electric Private Network\n* Port of Seattle\n* Japanese Companies Conexio, Hitachi Kokusai, Nippon Steel, Omron and Sharp\n* WEG Motor Manufacturer in Brazil\n* Elisa in Finland\n* Optus Stadium in Australia\n\n**Partnerships**\n\n* Google Cloud\n* EU's Hexa-X 6G Project\n* Brazil's Telecommunications R&amp;amp;D Center\n* AT&amp;amp;T tests to deploy virtualized and open RAN\n* Patents deal with Samsung\n* LG Uplus trial in South Korea\n*Bell Labs\n\n**5G is the Future**\n\nThe confusing nature of 5G could be holding back the market's valuation of Nokia. \n\n* Nokia is currently trading at a market cap of $22-23 billion even with a 2020 revenue of $24 billion.\n* A letter that Pekka recently published gives a decent explanation of what 5G is.\n   * In it, he admits \"\\[5G\\] is exciting, but it can seem a bit abstract.\" But then goes on to describe some real world examples that really helps explain it.\n   * \"Our partners saw unanticipated breakdowns and production line defects drop by 30% after installing smart video sensors in our manufacturing deployments. In the logistics sector, deploying augmented reality devices cut machine monitoring costs by half. In ports, remote-controlled cranes doubled productivity and eliminated staff injuries: an incredible 100% drop.\"\n* This seems to suggest that there may be more uses for 5G worldwide than cellular networks.\n* Nokia released a study stating that 5G could have an $8 trillion impact on global GDP by 2030.\n* Nokia and Ericcson may have a duopoly on 5G with Huawei and ZTE being banned in many countries. This trend may continue.\n* Some analysts have predicted massive (&amp;gt;1,000%) growth in the 5G market over the next 5 years.\n\n**Upcoming Events/Rumors**\n\n* **Capital Markets Day (3/18/21)**\n   * This is when we will get some true guidance on the future of the company. Not only will they lay out the strategic business plans for their 4 business segments as I mentioned above, but it should be when they make announcements toward potential a Dividend Reinstatement, Share Buyback, and future R&amp;amp;D decisions.\n* **Annual General Meeting (4/8/21)**\n   * Not sure what they plan to cover during this, but I would assume it will act as a follow up to Capital Markets Day\n* **Dividend Reinstatement**\n   * Most signs point to Nokia investing in R&amp;amp;D for a while, but based on Pekka's compensation package it should be back by 2023 at the latest.\n* **Share Buyback**\n   * Nokia did buy back 1.25 billion shares in 2015-16 and 1 billion shares in 2016-17. So the rumors they plan to do this again could be true. They can purchase up to a total of 550 million shares both this year and next year. 550 million because it correlates to 10% of the companies total outstanding shares.\n\n# Bearish (Risks/Cons)\n\n* The meme stock frenzy has a long-lasting impact on the opinion of this stock.\n* The dividend is not reinstated for another 3+ years.\n* Pekka does not have what it takes. Nokia is a sinking ship and cannot be turned around.\n* FCF is used solely for R&amp;amp;D and no shares are bought back over the next three years. The float does turn out to be too big to move significantly.\n* Nokia may not be undervalued and their revenue streams may continue to decline due to network share loses and pricing erosion.\n* Pekka has been very serious over the last two earning calls and things are going to get much worse/challenging before they get better.\n* With a new US administration in place, the trend of banning Huawei and ZTE that they started is lifted. These two competitors then undercut Nokia pricing.\n* 5G is no where near as big of an industry as the experts predict. Covid continues to slow the rollout of 5G well past 2030.\n* 5G is too confusing and never gets the buy in from today's investors.\n\nCowan Upgrades\n\nCowen Upgrades $NOK Citing Execution From New Ceo\n\nCowen adds its praise for¬†quarterly results, upgrading the stock to Outperform.\n\nFrom here, the demand environment looks to be \"very favorable,\" the firm says.\n\n\"What has changed is NOK's improving execution; we think upward trajectory is now clear and we expect meaningful incremental improvement from here, which while helping drive incremental revenue growth should especially help margin structure, and thereby EPS and cash flow,\" analyst Paul Silverstein says.\n\nMeanwhile, Silverstein says CEO Pekka Lundmark is following the playbook of Borje Ekholm's dramatic turn-around of Ericsson¬†(NASDAQ:ERIC); he's only one year in at Nokia and \"we think it is a safe assessment that further meaningful progress and attending upside lies ahead.\"\n\nCowen has raised its target on Nokia to $8 from $5, now implying 31.6% upside.\n\nCalls are also DIRT cheap, I think there is incredible growth over the long run AND the short term.\n\nI have 25 sept. 3 calls, 50 sept. 10 calls, 400 shares.", "id": "p3qlto", "created_utc": 1628877819.0, "score": 221, "upvote_ratio": 0.88, "num_comments": 94, "comments": [{"body": "\n**User Report**| | | |\n:--|:--|:--|:--\n**Total Submissions**|25|**First Seen In WSB**|6 months ago\n**Total Comments**|17|**Previous DD**|\n**Account Age**|6 months|[^scan ^comment ](https://www.reddit.com/message/compose/?to=VisualMod&subject=scan_comment&message=Replace%20this%20text%20with%20a%20comment%20ID%20(which%20looks%20like%20*h26cq3k*)%20to%20have%20the%20bot%20scan%20your%20comment%20and%20correct%20your%20first%20seen%20date.)|[^scan ^submission ](https://www.reddit.com/message/compose/?to=VisualMod&subject=scan_submission&message=Replace%20this%20text%20with%20a%20submission%20ID%20(which%20looks%20like%20*h26cq3k*)%20to%20have%20the%20bot%20scan%20your%20submission%20and%20correct%20your%20first%20seen%20date.)\n    \nHey /u/yiggyyaya, **positions or ban.** Reply to this with a screenshot of your entry/exit.", "score": 1, "replies": [{"body": "TLDR. Should I buy or not?", "score": 1, "replies": []}]}, {"body": "I didn‚Äôt understood Nokia as a meme stock. The float was way too much and way less shorted compared to GME and AMC. As a long term investment I see it still has lot of potential. \n\nHuawei is practically out of business and Ericsson and Nokia are players on the field. \nI don‚Äôt see reason why NOK would not go similar level than ERIC is now or even higher. Like Pekka said there is still so much to do before we see that but I have much more trust in NOK management than I have had in years. \n\nAnd, everyone who keeps switching between 3G or 4G to 5G is seeing already differences in the network speed. As more and more people will experience this is a competition on network speed again among the operators.", "score": 37, "replies": [{"body": "This is slightly off (NOK) topic, but: The speeds are not what makes or breaks 4G/5G operator USP right now. 4G can easily do 400mbit. Where I am sitting right now (outdoors) I get 38... \nFrom my conversation with people in that field, speed will not be the USP of 5G or 6G. At least not the next several years.", "score": 7, "replies": [{"body": "I think 4G is currently the minimum requirement. Make it 3G and people are already complaining. So I trust that all 3Gs will be eventually replaced by 5G. Especially on the more rural areas where connections are not properly done 4G -> 5G is a huge boost. But I do understand your point, I was quite happy with 4G before I switched to 5G.", "score": 4, "replies": []}]}, {"body": "Huawei is nowhere near practically out of business btw. \n\nThey are being pushed out of some western countries, which is great news as Pekka said they are picking up about 50% of that business, but in no way is Huawei ‚Äúpractically out of business‚Äù. In fact, I believe they are still the world‚Äôs biggest telecom equipment provider.", "score": 3, "replies": []}]}, {"body": "I like NOK because they are keeping Huawei out of Europe‚Äôs 5G network! Fuck the electronic Silk  (or Belt) Road initiative. fuck the CCP China is asshole", "score": 104, "replies": [{"body": "I'd like to second that, maybe even third too!", "score": 23, "replies": [{"body": "Fourth and fifth here", "score": 10, "replies": []}]}]}, {"body": "Finally a new NOK thread. Thumbs up.", "score": 48, "replies": []}, {"body": "Sideways? My NOK is up 47% since March or something. Works for me.", "score": 19, "replies": [{"body": "Yeah, I bought a small portion when it was down in 3.6 euro. Not sure if I should buy more", "score": 2, "replies": [{"body": "I buy all the dips, to me it‚Äôs the same as if you bought Amazon in ‚Äò99\n\nIt‚Äôs my retirement plan", "score": 6, "replies": []}]}]}, {"body": "I like it! The play has a lot of upside!  I'm holding this bitch until it hits $21, that my target price  bitches because 21 is my favorite number-  BLACK JACK A Winner!", "score": 17, "replies": []}, {"body": "I've been accumulating NOK for years anticipating their 5G rollout and more recently their dividend reinstatement. Finally turned a solid profit this year. Good long term play.", "score": 11, "replies": []}, {"body": "NOK NOK NOKin‚Äô on heavens door ‚Ä¶\nI got no money to invest anymore ‚Ä¶", "score": 10, "replies": []}, {"body": "What is this? Actual research and not rocket emoji?! This must be a troll WSB isn't smart enough to read.", "score": 9, "replies": []}, {"body": "I have got 1000 and will keep for now...", "score": 5, "replies": []}, {"body": "Nokia again! \nYay !!!!!!\nholding from 4.2 ü•≤", "score": 7, "replies": []}, {"body": "Anyone else find it amazing a NHL goalie can run a company the size of NOK?", "score": 10, "replies": [{"body": "That's Pekka Lindmark, not Lundmark.", "score": 9, "replies": [{"body": "No kidding??", "score": 2, "replies": []}]}, {"body": "Jesus fucking Christ‚Ä¶. This sub", "score": 5, "replies": [{"body": "I know, right??", "score": 2, "replies": []}]}, {"body": "[removed]", "score": -6, "replies": [{"body": "![gif](emote|free_emotes_pack|facepalm)", "score": 8, "replies": []}]}]}, {"body": "Nokia has actual value it's rated as a buy for a reason.", "score": 7, "replies": []}, {"body": "The only carrier that uses NOKIA is T-Mobile. The majority is utilizing Ericsson. \n\nAs a CPM for a wireless corp. we install the modifications to wireless facilities. That increases your insatiable bandwidth... assholes! \n\nWe prefer Ericsson as they are the 'best\" in the business for wireless. I fucking hate NOKIA equipment as it always fails due to manufacturer issues. supply is another issue for long lead items from NOKIA to replenish bad equipment, thus slowing down the overall deployment of 5G to your area. If you are rural you will NEVER see it. Costs too much, so choose wisely on your carrier. \n\nDisclaimer: I hold no positions in either stock, only giving my two cents to investors. I will say that the reason T-Mobile uses NOKIA is the price. Which may be all the catalyst you need? \n\nGL", "score": 9, "replies": [{"body": "T-Mobile now owns 20% of the US market due to the merger with sprint. \n\nThey're the 2nd largest phone company in the US (only behind Verizon) and they have deals with Deutsch telecom.\n\nNot saying you're wrong, just adding that \"only T-mobile\" is a bit misleading as its literally 1:5 americans. But if course most t mobile users aren't using nokia, they're using Apple or Samsung for their phones.", "score": 3, "replies": [{"body": "They are using apple and Samsung for their phones, but the 5G network is a whole lot of Nokia.", "score": 4, "replies": []}, {"body": "He's talking about mobile networking equipment you dumbass. Nokia doesn't make phones anymore", "score": 1, "replies": []}]}, {"body": "Not true, AT&T uses Nokia", "score": 2, "replies": [{"body": "What market?", "score": 1, "replies": [{"body": "United States\n\nhttps://www.google.com/amp/s/www.nokia.com/about-us/news/releases/2021/03/18/nokia-supports-5g-for-att-customers-with-five-year-c-band-deal/%3famp", "score": 2, "replies": [{"body": "so bagholder, this and whatever the link takes you too is crap. I literally build on all carriers and no where in the country uses Nokia equipment. \n\nSo think about  this tard... if Nokia were to provide equipment in the \"US\" they would need to build specific pieces of equipment for the exact frequency (from the spectrum purchased by individual carriers) where they do NOT overlap each other.\n\nThat would mean billions in pieces of RRUS and components. So your link has to be crap as only Ericsson has the bandwidth and capability to deploy nation wide. The equipment is NOT made overnight.  \n\nSo even if they broker a \"deal\" they will not deploy on it for years, after they migrate off the \"old\" Ericsson equipment. \n\nLast I heard we are bidding on swapping out flakey Nokia equipment fully from towers in the SE for Verizon to Ericsson. This is huge money for us, the equivalent of swapping out all the car parts in a car to make it go faster.\n\nIndustry experts will agree that Ericsson dominates the market, and again T-Mo uses it because they got a \"deal\" from Nokia.", "score": 1, "replies": [{"body": "The United States only makes up 1/3 of the worlds 5G market. Look at Nokia‚Äôs fundamentals, they‚Äôre solid. IMO it‚Äôs an extremely safe, sound investment. I am up 28%, $32K YTD.", "score": 1, "replies": [{"body": "I don't care since I'm not in it.\nGL with your trades.", "score": 2, "replies": [{"body": "Fair enough, thanks!", "score": 2, "replies": [{"body": "Maybe doesn't hurt to buy both Nokia and Ericcson", "score": 2, "replies": [{"body": "Not at all. If you believe in 5G then it would be an excellent strategy for diversification and possibly a buy in to a duopoly. All I can say is Ericsson‚Äôs essentially turned around the company 5 years ago similarly to what Nokia is trying to do right now.", "score": 2, "replies": [{"body": "Probably what I'll do. I own a couple of hundo shares of $NOK at like $4.3. Also sold a few puts - might sell some more puts if it drops again next week. Maybe I'll take some profits now and buy some $ERIC. My issue with $ERIC is the option chain fucking sucks. I love selling weekly covered calls / weekly puts and there is just no opportunity to do that with $ERIC.", "score": 2, "replies": [{"body": "Yeah that‚Äôs fair. I‚Äôm a long term buy and hold type investor. Have averaged up and down on NOK multiple times. It‚Äôs a huge % of my portfolio. I understand why people say buying too much if one stock is risky but in my opinion in a lot of ways it‚Äôs actually a lot less risky. But hey we‚Äôll see come 2030", "score": 1, "replies": [{"body": "I feel you man, I only trade stocks and options on companies that I wouldn't mind holding long term. The way I see it, selling puts locks me into a price lower than today's market price. I either net the premium or buy the stock at a price less than what I would have bought it anyway on that day. Couple that in with some dollar cost averaging on shares plus selling covered calls and I end up with a solid cost basis on some value stocks. I especially like $NOK because it's cheap (in absolute terms) and the collateral to sell puts isn't too high.\n\nDefinitely in the same camp as you. Would not mind accumulating shares and wait for 2030 :D", "score": 2, "replies": []}]}]}]}]}]}]}]}, {"body": "are you fucking retarded?", "score": 1, "replies": [{"body": "Going out on a limb here, but from your reply I know you are.", "score": 2, "replies": []}]}]}]}]}]}]}, {"body": ">\tThen it climbed back up to the low $4s, had a crazy January hitting $9.79 for about 10 seconds during to the meme stock frenzy, and has since returned to the high $3s low $4s after the Q4 earnings call.\n\n\nIt‚Äôs at $6.12 now you nonce. It‚Äôs been above $5 since the end of May.", "score": 5, "replies": []}, {"body": "Hey I got 165 of it at about 6$ each. Obvs I believe in nok. Even running an option with the expectation it might cross 7 before sept.   \nFingers crossed.", "score": 3, "replies": []}, {"body": "The current affordability of NOK compared to stocks like AMC and GME could offer the retail market another oppertunity for sqeeze getting in. Stock should definitely be getting more attention.", "score": 3, "replies": []}, {"body": "Don't buy calls this is a slow moving stock.  Shares only imo", "score": 2, "replies": []}, {"body": "NOK is a solid stock at $4-$4.50. At current prices? It has a lower value proposition.", "score": 2, "replies": []}, {"body": "How many DDs will be on how Nokia will be worth a shit until it actually is? Is there a way we can count how many DDs have ‚ÄúNokia‚Äù in the title within the last 2 years lol", "score": 1, "replies": []}, {"body": "I bought in at 5 bucks a share. Love the action lately.", "score": 1, "replies": []}, {"body": "Marketcap: 34 billion. Good luck to you bagholders", "score": 0, "replies": [{"body": "2021 revenue should be $26 billion. A 1.3x valuation is not out of line at all.", "score": 0, "replies": [{"body": "I Can make a revenue of 1 trillion if I want to, Doesnt mean it Will be 1 trillion profit. Would u give a fuck about Nokia before the ‚Äùshort squeeze‚Äù fiasco? Doubt it.", "score": -1, "replies": [{"body": "What does that even mean? A company‚Äôs market cap should reflect its revenue not its profit. Still not sure Nokia ever technically squeezed, short interest has always been under 1% for Nokia. And even if it did that was 6 months ago, get over it.", "score": 2, "replies": [{"body": "The market cap is how the market value the company from day to day retard.", "score": 0, "replies": [{"body": "Lol I know. So a market cap of $34 billion is appropriate. Honestly IMO it‚Äôs still quite undervalued.", "score": 1, "replies": [{"body": "No it isnt. And you didnt even know about the company a year ago dumbass", "score": 0, "replies": [{"body": "You‚Äôre right. Definitely never heard of Nokia until this year. I lived in a cave in the early 2000s and didn‚Äôt even know what a cell phone was until last week.", "score": 2, "replies": [{"body": "Okay so you have invested in Nokia since 2016 or what? Doubt it.", "score": 0, "replies": [{"body": "Of course not, they had a shit CEO and ineffective business model. Both of those things have changed in the last year. If you don‚Äôt believe in the company that‚Äôs totally fine. I will just continue to invest in the company as long as continue to like what I see. I am up 28%, $32K on my position YTD.", "score": 1, "replies": [{"body": "Lol so they replaced the CEO after the push on the stock or what?", "score": 0, "replies": [{"body": "That is correct. But I am long on the company and had I sold the tax man would‚Äôve gotten me. $9 is going to look like peanuts in 2030. But hey everyone has their own investment strategies. IMO real wealth is most easily generated by long term holds.", "score": 1, "replies": [{"body": "If that was the case, we would all be rich dumbass . Here we have 0.00014% on capital gains tax", "score": 1, "replies": []}]}, {"body": "Not sure why you edited this comment to change it from telling me I would‚Äôve double my money if I sold in January. But no Pekka was announced as the new CEO in March 2020. He was a former Nokia employee for about a decade in the 90s. He basically audited the company for a few months to figure out how to fix it. He took over in August 2020 and began to implement his plan. A year later it appears to be working, but we will see how it goes.", "score": 1, "replies": [{"body": "I did the edit Cuz the price is almost back to the peak. As far as I Can tell its a 5g only play. But hey Good luck with it", "score": 1, "replies": [{"body": "What does that mean, a 5G only play? Nokia is a telecommunications company so yes of course 5G makes up a substantial portion of their revenue. Also 5G is an industry that poised to have massive growth until 2030 which is when 6G is projected to potentially begin to rollout.", "score": 1, "replies": [{"body": "You just answered your own question there", "score": 1, "replies": []}]}]}]}]}]}]}]}]}]}]}]}]}]}]}, {"body": "Don‚Äôt listen to him/her. \nNOK is not having a good year, Ericsson got more contract, in USA. \n\nNOK has less orders than competitors, so maybe not a good idea", "score": -14, "replies": [{"body": "Bruh They lead in Europe contracts", "score": 9, "replies": []}, {"body": "blablabla....", "score": 3, "replies": []}]}, {"body": "Another garbage attempted pump and dump DD, same stock different day, really fucking sick and tired of these trash posts.", "score": -12, "replies": []}, {"body": "Nah let's stop this rn. We've seen how this ends", "score": 1, "replies": []}, {"body": "Is this financial advice?", "score": 1, "replies": []}, {"body": "[removed]", "score": 1, "replies": []}, {"body": "My $4C 1/20/23 going to print.", "score": 1, "replies": []}, {"body": "[removed]", "score": 1, "replies": [{"body": "This looks like spam. The mods have been notified.\n\n*I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/wallstreetbets) if you have any questions or concerns.*", "score": 1, "replies": []}]}]}
